Skip to main content
MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.515
-0.025 (-1.62%)
May 9, 2025, 10:32 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Collaborative and Other Agreements
28.99M
Log In
Log In
Log In
Log In
Upgrade
Collaborative and Other Agreements Growth
-75.70%
Log In
Log In
Log In
Log In
Upgrade
Monoclonal Antibody-based Therapeutics
17.94M
Log In
Log In
Log In
Log In
Upgrade
Monoclonal Antibody-based Therapeutics Growth
7.25%
Log In
Log In
Log In
Log In
Upgrade
Contract Manufacturing
9.83M
Log In
Log In
Log In
Log In
Upgrade
Contract Manufacturing Growth
-29.70%
Log In
Log In
Log In
Log In
Upgrade
Government Agreements
1.56M
Log In
Log In
Log In
Log In
Upgrade
Government Agreements Growth
-19.08%
Log In
Log In
Log In
Log In
Upgrade
Royalty
431.00K
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
58.75M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-61.33%
Log In
Log In
Log In
Log In
Upgrade